Collegium Pharmaceutical Financial Health
How is Collegium Pharmaceutical's financial position?
Financial Health Score2/6
Financial Health Score 2/6
Short Term Liabilities
Long Term Liabilities
Stable Cash Runway
Forecast Cash Runway
Financial Position Analysis
Short Term Liabilities: COLL's short term assets ($405.2M) do not cover its short term liabilities ($414.5M).
Long Term Liabilities: COLL's short term assets ($405.2M) do not cover its long term liabilities ($589.2M).
Debt to Equity History and Analysis
Debt Level: COLL's net debt to equity ratio (298.9%) is considered high.
Reducing Debt: COLL's debt to equity ratio has increased from 2.2% to 366.9% over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable COLL has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: COLL is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 12.1% per year.